EUVIMEDEUVIMED entdecken
Open Access

Cost analysis of vaccine-preventable diseases surveillance in Ethiopia

Nelly Mejia iD, Aschalew Abayneh Workineh, Eden Dagnachew Zeleke, Senait Alemayehu Beshah, Roopa Darwar iD, Mesfin Wossen, Mikias Alayu, Leuel Lisanwork, Getnet Yimer, Kassech Sintayehu Molla, Eshetu Wassie Asemahaegne, Zewdu Assefa Edea und 11 weitere

Journal of Public Health · 2026

DOI: 10.1093/pubmed/fdag056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Public Health, 2026. Verfasst von Nelly Mejia und 22 weiteren Autor:innen. Beteiligte Einrichtung: Global Immunization Division, Global Health Center, U.S. Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, Georgia, 30329, USA. Hauptthemen laut MEDLINE: Vaccine-Preventable Diseases, Costs and Cost Analysis, Population Surveillance. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: World Health Organization, Intramural CDC HHS, Ethiopian Public Health Institute, U.S. Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study evaluated the cost of the vaccine-preventable diseases (VPD) surveillance system in Ethiopia to inform budgeting for disease detection, prevention, and control, and planning for transitions from donor funding.

Methods

This cross-sectional retrospective, bottom-up micro-costing study collected data on resource utilization to conduct VPD surveillance during one fiscal year (2018–2019) in Ethiopia. The study covered 16 VPDs and costs from the government and partners perspective.

Results

The estimated economic costs of VPD surveillance in Ethiopia were US$69.11 million or US$0.70 per capita, while financial costs were US$26.83 million or US$0.27 per capita. The largest economic cost was for labor (41.0%) and the largest financial cost was for supplies (36.9%). Resources were mostly allocated to integrated, general disease surveillance (economic: 54.6%; financial: 50.7%), followed by surveillance for measles and rubella (economic: 15.9%; financial: 22.5%) and polio (economic: 12.4%; financial: 15.7%). The main funder was the Ethiopian Ministry of Health (economic: 78.8%; financial 62.6%), including donor resources channeled through the ministry.

Conclusions

Human resources were primary drivers of economic costs. Although the Ethiopian VPD surveillance system uses shared resources across multiple VPDs, resulting in scale efficiencies, and the Ethiopian government covers most of its economic costs, a substantial portion relies on direct external donor support.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccine-Preventable DiseasesCosts and Cost AnalysisPopulation SurveillanceEthiopiaHumansCross-Sectional StudiesRetrospective Studies

Stichwörter der Autor:innen

Ethiopiacosting analysispolio transitionsurveillancevaccine-preventable diseases

Autor:innen und Institutionen

  • Global Immunization Division, Global Health Center, U.S. Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, Georgia, 30329, USA.
  • Ethiopian Public Health Institute (EPHI), Gulelle Arbegnoch Street, Gulele Sub-City, Near Pasteur Square, P.O. Box 1242, Addis Ababa,Ethiopia.
  • Global One Health LLC, The Ohio State University, Bole Road, Noah Plaza Building, 2nd Floor, Bole Sub-City, District-03, Addis Ababa, 1000, Ethiopia.
  • Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, Global One Health initiative, The Ohio State University, N-1137 Doan Hall, 410 West 10th Ave, Columbus, Ohio, 43210, USA.
  • World Health Organization, Ethiopia Country Office, UNECA Compound, Zambezi Building, Addis Ababa,Ethiopia.
  • Division of Global Health Protection, Global Health Center, U.S. Centers for Disease Control and Prevention, Entoto Street, District 06, Addis Ababa, 1014,Ethiopia.

ORCID-Profile: Nelly Mejia, Roopa Darwar

Förderung

  • World Health Organization
  • Intramural CDC HHS
  • Ethiopian Public Health Institute, U.S. Centers for Disease Control and Prevention

Zitieren

APA

Mejia, N., Workineh, A. A., Zeleke, E. D., Beshah, S. A., Darwar, R., Wossen, M., Alayu, M., Lisanwork, L., Yimer, G., Molla, K. S., Asemahaegne, E. W., Edea, Z. A., Dugasa, Y., Assefa, E., Gebresilassie, F. E., An, Q., Dahl, B. A., Loharikar, A., Mwenda, J. M., …, & Pallas, S. W. (2026). Cost analysis of vaccine-preventable diseases surveillance in Ethiopia. Journal of Public Health. https://doi.org/10.1093/pubmed/fdag056

Vancouver

Mejia N, Workineh AA, Zeleke ED, Beshah SA, Darwar R, Wossen M, et al. Cost analysis of vaccine-preventable diseases surveillance in Ethiopia. Journal of Public Health. 2026. doi:10.1093/pubmed/fdag056

BibTeX
@article{Mejia2026,
  author = {Mejia, Nelly and Workineh, Aschalew Abayneh and Zeleke, Eden Dagnachew and Beshah, Senait Alemayehu and Darwar, Roopa and Wossen, Mesfin and Alayu, Mikias and Lisanwork, Leuel and Yimer, Getnet and Molla, Kassech Sintayehu and Asemahaegne, Eshetu Wassie and Edea, Zewdu Assefa and Dugasa, Yohannes and Assefa, Esete and Gebresilassie, Frehywot Eshetu and An, Qian and Dahl, Benjamin A and Loharikar, Anagha and Mwenda, Jason M and Wang, Shu-Hua and Bose, Anindya Sekhar and Abate, Ebba and Pallas, Sarah Wood},
  title = {Cost analysis of vaccine-preventable diseases surveillance in Ethiopia},
  journal = {Journal of Public Health},
  year = {2026},
  doi = {10.1093/pubmed/fdag056}
}
Kostenlos starten →